Source:http://linkedlifedata.com/resource/pubmed/id/12444818
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-26
|
| pubmed:abstractText |
Pathological gambling is a disabling and highly prevalent impulse-control disorder not otherwise specified (NOS). According to the hypothesis of abnormal serotonin function in the pathophysiology of poor impulse control and pathological gambling, we assessed the efficacy and tolerability of nefazodone, a 5-HT antagonist reported to be effective in other impulse-control disorders NOS, in the treatment of pathological gambling.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1034-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:articleTitle |
Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
|
| pubmed:affiliation |
Department of Psychiatry, Mount Sinai School of Medicine, New York, N.Y., USA.
|